DGAP-News: Epigenomics AG / Key word(s): Product Launch 19.12.2017 / 08:45 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG gets CE-IVD Mark for Lung Cancer Test Epi proLung(R) Berlin (Germany) and Germantown, MD (U.S.A.), December 19, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY, “Company”) announced […]
Author: mark
29. November 2017
Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)
DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 29.11.2017 / 21:41 The issuer is solely responsible for the content of this announcement. Press release Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand) Berlin (Germany) and Germantown, MD (U.S.A.), November 29, 2017 […]
21. November 2017
Epigenomics AG announces recent payment decision by CMS
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 21.11.2017 / 22:35 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG announces recent payment decision by CMS Berlin (Germany) and Germantown, MD (U.S.A.), November 21, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced the Centers of Medicare & […]
15. November 2017
Epigenomics AG Announces 2017 Third Quarter and Nine Months Financial Results
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 15.11.2017 / 08:35 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2017 Third Quarter and Nine Months Financial Results – Third quarter performance in line with expectations; 2017 adj. EBITDA outlook improved – Financial position significantly strengthened […]
08. November 2017
Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs
DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 08.11.2017 / 10:36 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Appointment of Director Reimbursement and Medical Affairs Berlin (Germany) and Germantown, MD (U.S.A.), November 8, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced today that […]
05. November 2017
Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and Chief Scientific Officer
DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 05.11.2017 / 23:11 The issuer is solely responsible for the content of this announcement. Press release Supervisory Board of Epigenomics AG Appoints Dr. Jorge Garces as President and Chief Scientific Officer – Dr. Jorge Garces is a proven senior executive with deep technology and development expertise […]